vitiligo
Conditions
Interventions
None listed
Sponsors
Department of Dermatology, Tongji Hospital, Wuhan, Hubei, China
Eligibility
Sex/Gender
All
Age
6 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. The age range is 6-60 years old (children: 6-12 years old, teenagers: 13-17 years old, adults: 18-60 years old); 2. Patients who have been diagnosed with vitiligo by experienced doctors using Wood's lamp and have completed various inspections and epidemiological investigations; 3. First-diagnosed patients with vitiligo who have not received any drug treatment within six months before the diagnosis; 4. Vitiligo patients who voluntarily participate in this trial, can receive standardized treatment for 3 months, and return to the clinic on time; 5. Good compliance, willing to cooperate with the research, and agree to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with skin-related comorbidities, such as diabetes mellitus, pernicious anemia, pernicious neoplasm, psoriasis, atopic dermatitis, pemphigus, severe infectious diseases, cardiopulmonary insufficiency, hepatic and renal insufficiency, coagulation abnormalities or other serious systemic diseases; 2. Patients with contraindications to systemic hormone therapy, such as peptic ulcer, recent gastrointestinal surgery, osteoporosis, fracture, epilepsy, hyperadrenalism, corneal ulcer, glaucoma, severe hypokalemia, cortisolism, etc.; 3. Patients with diagnosed severe neuropsychiatric disorders; 4. Women during lactation and pregnancy; 5. Patients who for any reason have not been on standardized continuous treatment for 3 months or have not been followed up at 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 25-hydroxyvitamin D;Lymphocyte;psychological examination;Thyroid;microelement; | — |
Countries
China
Contacts
Public ContactYunhua Deng
Department of Dermatology, Tongji Hospital, Wuhan, Hubei, China
Outcome results
None listed